The following table summarizes the changes in the Company’s investments in Alzamend common stock during the nine months ended September 30, 2022: (Details) - USD ($)		3 Months Ended	9 Months Ended
		Sep. 30, 2022	Sep. 30, 2022	Sep. 30, 2021
Restructuring Cost and Reserve [Line Items]
Securities purchase agreement		$ 1,669,000	$ 1,669,000
Unrealized loss in common stock of Alzamend				$ 449,000
Common Stock [Member]
Restructuring Cost and Reserve [Line Items]
Securities purchase agreement
Unrealized loss in common stock of Alzamend
Alzamend [Member] | Common Stock [Member]
Restructuring Cost and Reserve [Line Items]
Begining balance (in shares)			6,947,000
Begining balance (in dollars per shares)			$ 1.90
Begining balance			$ 13,230,000
Securities purchase agreement (in shares)	[1]		2,667,000
Securities purchase agreement (in dollars per shares)	[1]		$ 1.50
Securities purchase agreement	[1]		$ 4,000,000
Open market purchases after initial public offering (in shares)			801,000
Open market purchases after initial public offering (in dollars per shares)			$ 1.05
Open market purchases after initial public offering			$ 840,000
Unrealized loss in common stock of Alzamend			$ (5,676,000)
Ending balance (in shrares)		10,415,000	10,415,000
Ending balance (in dollars per shares)		$ 1.19	$ 1.19
Ending balance		$ 12,394,000	$ 12,394,000

[1] Pursuant to the March 9, 2021 securities purchase agreement, in aggregate, Alzamend agreed to sell up to 6,666,667 shares of its common stock to Ault Lending for $10.0 million, or $1.50 per share, and issue to Ault Lending warrants to acquire 3,333,334 shares of Alzamend common stock with an exercise price of $3.00 per share. As of December 31, 2021, Ault Lending funded $6.0 million, including the conversion of notes and advances of $0.8 million, and the remaining $4.0 million was funded upon Alzamend achieving certain milestones during the nine months ended September 30, 2022.